Lyka Labs informs about outcome of board meeting

04 Feb 2025 Evaluate
Lyka Labs has informed that the Board of Directors of the Company at its meeting held today i.e. 4th February, 2025, has considered and approved the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended 31st December, 2024 and the said Financial Results have been reviewed by the Audit Committee. In this regard, a copy of the said Financial Results along with the Limited Review Reports of the Auditors of the Company thereon is enclosed. These are also being made available on the website of the Company at www.lykalabs.com. The meeting of the Board of Directors commenced at 1.15 pm and concluded at 3:05 pm.

The above information is a part of company’s filings submitted to BSE.

Lyka Labs Share Price

77.17 0.00 (0.00%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1722.40
Dr. Reddys Lab 1240.70
Cipla 1501.00
Zydus Lifesciences 913.15
Lupin 2103.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×